• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人原发性巨细胞病毒感染中病毒特异性CD8 T细胞的主导地位。

Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection.

作者信息

Sester Martina, Sester Urban, Gärtner Barbara C, Girndt Matthias, Meyerhans Andreas, Köhler Hans

机构信息

Medical Department IV, Division of Nephrology, University of the Saarland, Homburg, Germany.

出版信息

J Am Soc Nephrol. 2002 Oct;13(10):2577-84. doi: 10.1097/01.asn.0000030141.41726.52.

DOI:10.1097/01.asn.0000030141.41726.52
PMID:12239248
Abstract

Cellular immune responses are of high importance in initiating and maintaining immunity against virus infections. Whereas the cellular immune response during persistent cytomegalovirus (CMV) infection is well assessable, the individual contribution of CD4 and CD8 T cell responses during primary infection has not been described. A novel whole-blood assay, which relies on the flow-cytometric detection of antigen-induced cytokine expression, was used to characterize CMV-specific CD4 and CD8 T cell responses during primary infection of CMV seronegative recipients of a renal allograft from a CMV seropositive donor. These T cell responses were compared with long-term CMV-positive patients with known history of transplantation-related seroconversion. Results were further correlated to CMV load and serum IgG and IgM. The long-term seroconverted patients consistently showed a dominant CMV-specific CD4 T cell response (median frequencies: CD4, 1.12% [range, 0.35 to 8.10%] versus CD8 0.13% [range, <0.05 to 0.55%]). In contrast, during primary infection, the cellular immune response is strongly dominated by CMV-specific CD8 T cells (median peak frequencies: CD4, 1.24% [range, 0.21 to 1.60%] versus CD8, 2.47% [range, 1.34 to 6.67%]). Upon receipt of ganciclovir, viral load as well as CMV-specific CD8 responses decreased. The frequency of the respective CD4 T cells fluctuated during decrease of CMV load and became dominant over CMV-specific CD8 T cell responses. These results are consistent with the view of an effective direct antiviral activity of CD8 T cells, which is most critical during periods of high viremia. Later on during persistent infection, CD4 T cells dominate the immune response to support the state of antiviral immunity.

摘要

细胞免疫反应在启动和维持针对病毒感染的免疫中具有高度重要性。虽然持续性巨细胞病毒(CMV)感染期间的细胞免疫反应易于评估,但原发性感染期间CD4和CD8 T细胞反应的个体贡献尚未得到描述。一种新型全血检测方法,该方法依赖于对抗原诱导的细胞因子表达进行流式细胞术检测,用于表征来自CMV血清阳性供体的肾移植CMV血清阴性受者原发性感染期间的CMV特异性CD4和CD8 T细胞反应。将这些T细胞反应与有移植相关血清转化已知病史的长期CMV阳性患者进行比较。结果进一步与CMV载量以及血清IgG和IgM相关。长期血清转化患者始终表现出占主导地位的CMV特异性CD4 T细胞反应(中位频率:CD4,1.12%[范围,0.35%至8.10%]对CD8 0.13%[范围,<0.05%至0.55%])。相比之下,在原发性感染期间,细胞免疫反应强烈地由CMV特异性CD8 T细胞主导(中位峰值频率:CD4,1.24%[范围,0.21%至1.60%]对CD8,2.47%[范围,1.34%至6.67%])。接受更昔洛韦后,病毒载量以及CMV特异性CD8反应降低。在CMV载量下降期间,相应CD4 T细胞的频率波动,并超过CMV特异性CD8 T细胞反应而占主导地位。这些结果与CD8 T细胞具有有效的直接抗病毒活性的观点一致,这在高病毒血症期间最为关键。在持续性感染后期,CD4 T细胞主导免疫反应以维持抗病毒免疫状态。

相似文献

1
Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection.人原发性巨细胞病毒感染中病毒特异性CD8 T细胞的主导地位。
J Am Soc Nephrol. 2002 Oct;13(10):2577-84. doi: 10.1097/01.asn.0000030141.41726.52.
2
[Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].[通过细胞因子流式细胞术监测肾移植受者中巨细胞病毒特异性CD4+和CD8+ T细胞反应]
Mikrobiyol Bul. 2016 Apr;50(2):224-35.
3
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.针对亚临床巨细胞病毒感染的T细胞免疫可减轻心脏移植疾病。
Circulation. 2006 Oct 10;114(15):1608-15. doi: 10.1161/CIRCULATIONAHA.105.607549. Epub 2006 Oct 2.
4
Rapid T cell repopulation after rabbit anti-thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus.兔抗胸腺细胞球蛋白(rATG)治疗后 T 细胞快速重建主要由巨细胞病毒驱动。
Clin Exp Immunol. 2012 Sep;169(3):292-301. doi: 10.1111/j.1365-2249.2012.04622.x.
5
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation.病毒特异性CD4 T细胞水平与巨细胞病毒控制相关,并可预测肾移植后病毒诱导的疾病。
Transplantation. 2001 May 15;71(9):1287-94. doi: 10.1097/00007890-200105150-00018.
6
Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.基于四聚体的方法对去T细胞干细胞移植物及移植后巨细胞病毒(CMV)特异性CD8 + T淋巴细胞进行定量分析,可能会识别出有进行性CMV感染风险的患者。
Blood. 2001 Sep 1;98(5):1358-64. doi: 10.1182/blood.v98.5.1358.
7
Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.肺移植受者初次感染后,肺移植组织和血液中持续存在巨细胞病毒特异性记忆反应。
J Immunol. 2006 Feb 15;176(4):2625-34. doi: 10.4049/jimmunol.176.4.2625.
8
Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient.更昔洛韦治疗巨细胞病毒感染期间的病毒逃逸与T细胞免疫:一例胰肾移植受者的病例报告
Transplantation. 2003 Mar 15;75(5):724-7. doi: 10.1097/01.TP.0000052664.18029.E6.
9
Properties of CD4(+) T cells in human cytomegalovirus infection.人巨细胞病毒感染中CD4(+) T细胞的特性
Hum Immunol. 2004 May;65(5):486-92. doi: 10.1016/j.humimm.2004.02.020.
10
Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia.外周血淋巴细胞亚群CD4+和CD8+细胞对肾移植巨细胞病毒血症患者的预后影响
Transplant Proc. 2009 Jun;41(5):1639-42. doi: 10.1016/j.transproceed.2009.01.085.

引用本文的文献

1
Comprehensive insights into cytomegalovirus anterior segment infections: A narrative review.巨细胞病毒眼前节感染的综合见解:一项叙述性综述。
Taiwan J Ophthalmol. 2025 Jun 10;15(2):212-217. doi: 10.4103/tjo.TJO-D-25-00032. eCollection 2025 Apr-Jun.
2
The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis.巨细胞病毒感染对多发性硬化症中自然杀伤细胞和CD8 + T细胞表型的影响
Biology (Basel). 2024 Feb 28;13(3):154. doi: 10.3390/biology13030154.
3
Cytomegalovirus Anterior Uveitis: Clinical Manifestations, Diagnosis, Treatment, and Immunological Mechanisms.
巨细胞病毒前葡萄膜炎:临床表现、诊断、治疗和免疫机制。
Viruses. 2023 Jan 9;15(1):185. doi: 10.3390/v15010185.
4
Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients.肝移植受者中巨细胞病毒感染转化为疾病时的免疫抑制方案
Caspian J Intern Med. 2022 Fall;13(4):721-727. doi: 10.22088/cjim.13.4.721.
5
The establishment of a cytomegalovirus -specific CD8 T-cell threshold by kinetic modeling for the prediction of post-hemopoietic stem cell transplant reactivation.通过动力学建模建立巨细胞病毒特异性CD8 T细胞阈值以预测造血干细胞移植后的再激活。
iScience. 2022 Oct 12;25(11):105340. doi: 10.1016/j.isci.2022.105340. eCollection 2022 Nov 18.
6
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021.移植环境中的巨细胞病毒:我们现在在哪里,下一步会发生什么?来自 2021 年国际巨细胞病毒研讨会的报告。
Transpl Infect Dis. 2022 Dec;24(6):e13977. doi: 10.1111/tid.13977. Epub 2022 Nov 11.
7
NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant.NK 和 CD8+ T 细胞表型可预测肾移植后 CMV 病毒血症的发生和控制。
JCI Insight. 2021 Nov 8;6(21):e153175. doi: 10.1172/jci.insight.153175.
8
Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update.巨细胞病毒特异性免疫监测在实体器官移植受者巨细胞病毒管理中的应用:临床最新进展
Diagnostics (Basel). 2021 May 13;11(5):875. doi: 10.3390/diagnostics11050875.
9
Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition.重组单纯疱疹病毒载体:持久的免疫应答和对猴免疫缺陷病毒 SIVmac239 获得性感染的持久保护。
J Virol. 2021 Jun 24;95(14):e0033021. doi: 10.1128/JVI.00330-21.
10
Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis.溃疡性结肠炎患者的人巨细胞病毒和 Epstein-Barr 病毒特异性免疫。
Clin Exp Med. 2021 Aug;21(3):379-388. doi: 10.1007/s10238-021-00702-2. Epub 2021 Mar 26.